Bianco I, Cappabianca M P, Foglietta E, Lerone M, Deidda G, Morlupi L, Grisanti P, Ponzini D, Rinaldi S, Graziani B
Associatione Nazionale per la lotta contro le Microcitemie in Italia, Rome, Italy.
Haematologica. 1997 May-Jun;82(3):269-80.
Current application of molecular biology techniques to the study of the DNA of globin genes has confirmed the existence of silent alpha and beta thalassemias; which had already been reported on the basis of red blood cell parameters and family studies. The present work was aimed at analyzing all the aspects of the phenotype of the most common varieties of silent thalassemia.
Groups of heterozygous carriers of these varieties were examined using established techniques that determined all hematologic, hemoglobin (electrophoresis and measurement of Hb A2 and Hb F levels), and globin synthesis (evaluation of the alpha/beta ratio) parameters. Furthermore, all subjects underwent a complete molecular study of the alpha and beta globin genes by means of the ARMS, SSCP, DGGE, PCR and Southern blotting techniques.
Many of these silent varieties (beta + thalassemia due to the -101 C-->T mutation; alpha + thalassemia from a deletion or point mutation of an alpha gene; alpha alpha alpha triplication) are quite frequent in the overall group of thalassemias. It is therefore important for the operators in the field of thalassemia diagnosis to possess exact knowledge of them especially in order to prevent thalassemia major.
目前分子生物学技术应用于珠蛋白基因DNA的研究,已证实了静止型α和β地中海贫血的存在;此前已根据红细胞参数和家系研究报告过这些类型。本研究旨在分析最常见的静止型地中海贫血各类型表型的所有方面。
使用已确立的技术对这些类型的杂合子携带者群体进行检查,这些技术可测定所有血液学、血红蛋白(电泳及Hb A2和Hb F水平测定)以及珠蛋白合成(α/β比值评估)参数。此外,所有受试者通过扩增阻滞突变系统(ARMS)、单链构象多态性(SSCP)、变性梯度凝胶电泳(DGGE)、聚合酶链反应(PCR)和Southern印迹技术对α和β珠蛋白基因进行全面的分子研究。
1)β珠蛋白基因启动子的-101 C→T突变表现为血液学指标正常,Hb A2水平常略有升高,α/β珠蛋白合成比值略大于1;2)由IVS II 844 C→G突变导致的β⁺地中海贫血,其表型更接近正常;3)-α3.7缺失I型通常具有完全静止的表型;4)α Ncol突变若位于α2基因上,几乎总是产生亚静止表型,若位于α1基因上则产生静止表型;5)由α2 Hphl突变导致的α⁺地中海贫血,在某些情况下表现为亚静止表型,在其他情况下表现为静止表型;6)α基因三倍体产生的表型与β珠蛋白基因启动子的-101 C→T突变相当相似,即通常为静止型。
许多这些静止型类型(-101 C→T突变导致的β⁺地中海贫血;α基因缺失或点突变导致的α⁺地中海贫血;ααα三倍体)在地中海贫血总体群体中相当常见。因此,地中海贫血诊断领域的工作人员准确了解它们非常重要,特别是为了预防重型地中海贫血。